Perspectives on Limitations to Patentability- Report No. I of a Webinar Series on Reinterpreting TRIPS in the Life Sciences

Research output: Other contributionNet publication - Internet publicationCommunication

Standard

Perspectives on Limitations to Patentability- Report No. I of a Webinar Series on Reinterpreting TRIPS in the Life Sciences. / Wested, Jakob; Minssen, Timo.

2017.

Research output: Other contributionNet publication - Internet publicationCommunication

Harvard

Wested, J & Minssen, T 2017, Perspectives on Limitations to Patentability- Report No. I of a Webinar Series on Reinterpreting TRIPS in the Life Sciences..

APA

Wested, J., & Minssen, T. (2017, Jun 16). Perspectives on Limitations to Patentability- Report No. I of a Webinar Series on Reinterpreting TRIPS in the Life Sciences.

Vancouver

Wested J, Minssen T. Perspectives on Limitations to Patentability- Report No. I of a Webinar Series on Reinterpreting TRIPS in the Life Sciences. 2017.

Author

Wested, Jakob ; Minssen, Timo. / Perspectives on Limitations to Patentability- Report No. I of a Webinar Series on Reinterpreting TRIPS in the Life Sciences. 2017.

Bibtex

@misc{83fe2d12de614a8aaf609c450ebb1d39,
title = "Perspectives on Limitations to Patentability- Report No. I of a Webinar Series on Reinterpreting TRIPS in the Life Sciences",
abstract = "This report is based on the material and input that was presented and discussed at the webinar with the title: “Perspectives on limitations to patentability”. The Webinar and the theme where introduced by Prof. Timo Minssen. Then Prof. Nari Lee gave a presentation introducing some of the context and considerations related to TRIPS art 27 and the concept of technological neutrality. This was followed by Dr. Mike Snodin presentation on some central points and arguments from his recent article considering the so-called “Correa Guidelines” and their compatibility with the obligations enshrined in TRIPS art 27. After the introduction and the two presentations, the open discussion turned to questions, comments and considerations of related issues such as the need for alternative incentives, purpose bound product protection, user driven solutions and post-grant instruments. Suggested citation: Wested, Jakob and Minssen, Timo, Trips and the Life Sciences - Perspectives on Limitations to Patentability (June 15, 2017). Available at SSRN: https://ssrn.com/abstract=2986751",
keywords = "Faculty of Law, TRIPS agreement, Patents, Correa guidelines, Technological neutrality, non-discrimination, Life science, Pharmaindustry, Biotechnology",
author = "Jakob Wested and Timo Minssen",
year = "2017",
month = "6",
day = "16",
language = "English",
type = "Other",

}

RIS

TY - ICOMM

T1 - Perspectives on Limitations to Patentability- Report No. I of a Webinar Series on Reinterpreting TRIPS in the Life Sciences

AU - Wested, Jakob

AU - Minssen, Timo

PY - 2017/6/16

Y1 - 2017/6/16

N2 - This report is based on the material and input that was presented and discussed at the webinar with the title: “Perspectives on limitations to patentability”. The Webinar and the theme where introduced by Prof. Timo Minssen. Then Prof. Nari Lee gave a presentation introducing some of the context and considerations related to TRIPS art 27 and the concept of technological neutrality. This was followed by Dr. Mike Snodin presentation on some central points and arguments from his recent article considering the so-called “Correa Guidelines” and their compatibility with the obligations enshrined in TRIPS art 27. After the introduction and the two presentations, the open discussion turned to questions, comments and considerations of related issues such as the need for alternative incentives, purpose bound product protection, user driven solutions and post-grant instruments. Suggested citation: Wested, Jakob and Minssen, Timo, Trips and the Life Sciences - Perspectives on Limitations to Patentability (June 15, 2017). Available at SSRN: https://ssrn.com/abstract=2986751

AB - This report is based on the material and input that was presented and discussed at the webinar with the title: “Perspectives on limitations to patentability”. The Webinar and the theme where introduced by Prof. Timo Minssen. Then Prof. Nari Lee gave a presentation introducing some of the context and considerations related to TRIPS art 27 and the concept of technological neutrality. This was followed by Dr. Mike Snodin presentation on some central points and arguments from his recent article considering the so-called “Correa Guidelines” and their compatibility with the obligations enshrined in TRIPS art 27. After the introduction and the two presentations, the open discussion turned to questions, comments and considerations of related issues such as the need for alternative incentives, purpose bound product protection, user driven solutions and post-grant instruments. Suggested citation: Wested, Jakob and Minssen, Timo, Trips and the Life Sciences - Perspectives on Limitations to Patentability (June 15, 2017). Available at SSRN: https://ssrn.com/abstract=2986751

KW - Faculty of Law

KW - TRIPS agreement, Patents, Correa guidelines, Technological neutrality, non-discrimination, Life science, Pharmaindustry, Biotechnology

UR - https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2986751

UR - http://jura.ku.dk/ciir/english/research/trips/

M3 - Net publication - Internet publication

ER -

ID: 179440171